Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Hepathine L L-Ornithine and L-Aspartate Injection
Hepathine L, offered by Lexaro Healthcare, contains a combination of L-Ornithine and L-Aspartate in an injectable formulation. Each dose is meticulously crafted to ensure high quality and efficacy.
Uses of Hepathine L L-Ornithine and L-Aspartate Injection
Hepathine L is primarily prescribed for the treatment of hepatic encephalopathy, a condition associated with severe liver disease. It is also used to support liver function and improve detoxification processes in patients with chronic liver conditions.
Benefits of Hepathine L L-Ornithine and L-Aspartate Injection
Enhances liver function and promotes detoxification.
Reduces symptoms of hepatic encephalopathy, improving mental status and quality of life.
Supports overall liver health in patients with chronic liver disease.
Well-tolerated with a favorable safety profile when used as directed.
Mechanism of Action of Hepathine L L-Ornithine and L-Aspartate Injection
L-Ornithine and L-Aspartate act as ammonia detoxifying agents. They promote the conversion of ammonia into urea, which is then excreted from the body. This action helps to reduce elevated ammonia levels in patients with liver dysfunction, thereby alleviating symptoms of hepatic encephalopathy and supporting overall liver function.